The global nephrology stents and catheters market is estimated to project growth at a CAGR of around 5% to 6% during the forecast period 2022-2032. Increasing emphasis on the development of advanced application-specific nephrology devices with innovative technology is estimated to favor the demand for nephrology stents and catheters in the global market.
| Report Attribute | Details |
| Nephrology Stents and Catheters Market Projected Growth Rate (2022-2032) | 5% to 6% CAGR |
Nephrology stents and catheters are one of the most crucial medical devices and treatment options available in the field of nephrology for drainage of obstructed urine in patients. These medical devices are used when there is a blockage in one or both the ureters. They are generally inserted under the medication of a common anesthetic that assists in the temporary diversion of urine from the blockage.
Catheters are thin tubes made of medical-grade materials that are inserted into the bladder, kidney, or urethra followed by stents using a guidewire, which is placed by a balloon. In case of urine blockage, these catheters are used to drain the blockade. Demand for nephrology stents and catheters is growing at a rapid pace, owing to the doctors' inclination toward the use of these medical devices as a primary treatment option where antibiotic becomes ineffective.
Nephrology stents and catheters are increasingly being used for the treatment in nephritic cases such as straining on urination, urine retention, obstructed urethra, and interrupted urine stream. They are also finding a wide range of applications in surgical procedures as well as in monitoring the urine output post-surgery or in a critically ill patient. This is estimated to bolster the demand for nephrology stents and catheters in the global market.
A percutaneous nephrostomy is the insertion and placement of a thin, flexible rubber tube catheter through the skin into the kidney to drain the urine. These procedures are particularly used during the treatment of kidney stones.
Over the past couple of years, a significant rise in burden of nephritic diseases, such as kidney stones, is being witnessed all over the world, primary reasons being excessive consumption of caffeine, sugar, and salt, boosting the demand for assistive medical devices. According to a report by the National Institute of Diabetes and Digestive and Kidney Diseases, approximately 11% of men and 6% of women in the U.S. are estimated to have kidney stones at least once in their lifetime.
As nephrology stents and catheters are extensively used during the treatment of kidney stones, growing prevalence of such diseases is projected to create lucrative sales opportunities in the global market.
In addition to this, growing usage of nephrology stents and catheters in the treatment of urinary tract infection (UTI) infection, urinary incontinence, and benign prostate hyperplasia among others is estimated to further augment the demand in the market.
Despite several benefits associated with nephrology stents and catheters, risk of irregular peristalsis and encrustation, pain, discomfort, and infection caused by the ureteral tissues irritation post insertion of these devices is estimated to hamper the sales in the global market.
In addition to this, high cost of these medical devices, need for well-trained and qualified personnel for insertion, and catheterization & stenting challenges in percutaneous nephrostomy are factors further hindering growth in the nephrology stents and catheters market.
FMI states that North America is projected to emerge as the most lucrative market for nephrology stents and catheters during the forecast period 2022-2032.
The prevalence of cancer of reproductive organs such as the ovary, bladder, prostate, cervix, uterus, and others is increasing at a robust pace across North America, creating strong demand for diagnostics and treatment in the region. According to an estimated by the America Cancer Society, around 19,880 women are will be diagnosed with ovarian cancer and nearly 12,810 women will to die due to the disease across the U.S. in the year 2022.
Nephrology stents and catheters play a vital role in the treatment of cancer of reproductive organs for the placement of therapeutics for the treatment. Hence, this rise in incidence of cancers is estimated to bolster the demand in the North America market.
As per Future Market Insights, Europe is anticipated to account for a significant share in the global nephrology stents and catheters market between 2022 and 2032.
With increasing aged population and growing incidence of complications related to kidney, urinary tract, bladder, demand for nephrology devices is rapidly increasing. Hence, key players in the market are increasingly focusing on research and development activities for launching novel products.
For instance, in 2021, Medtronic, an Irish manufacturer of medical devices announced launching a new Chameleon balloon catheter for percutaneous transluminal angioplasty (PTA) in selected countries such as Italy, Germany, Spain, Turkey, Portugal, and South Africa. The device enables the infusion of therapeutic drugs or diagnostic fluids through the integrated injection port located near the center of the balloon. A slew of such new product launches is estimated to bolster the sales of nephrology stents and catheters in the Europe market.
Some of the leading players in the nephrology stents and catheters market Ameco Medical Industries, Medi-globe Corporation, Medtronic, Envaste Limited, Cardinal Health Inc., Boston Scientific Corporation, Merit Medical Systems, UROMED Angiodynamics, Inc., C. R. Bard, Inc., Teleflex Incorporated, and Rocamed.
The market for wound measurement devices is highly fragment and competitive, attributed to large presence of local and global players and increasing research and development activities for new products launches by key companies.
| Report Attribute | Details |
| Growth Rate | CAGR of 5% to 6% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Countries Covered |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
By Product Type:
By End User:
By Region:
FMI projects the sales of nephrology stents and catheters in the market is expected to rise at 5% to 6% value CAGR by 2032
The global nephrology stents and catheters market is expected to be dominated by North America the forecast period 2022-2032.
Ameco Medical Industries, Medi-globe Corporation, Medtronic, Envaste Limited, Cardinal Health Inc., Boston Scientific Corporation, Merit Medical Systems, UROMED, Angiodynamics, Inc., C. R. Bard, Inc., Teleflex Incorporated, Rocamed, and others are some of the leading players in the prominent nephrology stents and catheters market.
Explore Similar Insights
Nephrology Stents and Catheters Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
